Form 13-F position report

SPRINGWORKS THERAPEUTICS IN

Reported by LORD ABBETT & CO LLC

SWTX CUSIP 85205L107 Manager CIK 0000728100

Reported 2,073,970 shares, down 243,840 (10.5%) from the prior quarter.

Reported value -31.5%; share count -10.5% vs. the prior quarter.

Reduced
% of reported 13F value 0.26% This manager · Q2 2024
Shares 2,073,970 Quarter-end amount reported
Reported value $78,126,000 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 23490000
2022-03-31 11629000
2022-06-30 0
2024-03-31 114083000
2024-06-30 78126000
2024-09-30 34274000
2024-12-31 34172000
2025-03-31 16499000
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for SPRINGWORKS THERAPEUTICS IN held by LORD ABBETT & CO LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -373,874 (-100.0%) 0 $0 2025-08-14
Q1 2025 Reduced 373,874 -571,934 (-60.5%) 0.06% $16,499,000 2025-05-13
Q4 2024 Reduced 945,808 -123,930 (-11.6%) 0.11% $34,172,000 2025-02-14
Q3 2024 Reduced 1,069,738 -1,004,232 (-48.4%) 0.11% $34,274,000 2024-11-14
Q2 2024 Reduced 2,073,970 -243,840 (-10.5%) 0.26% $78,126,000 2024-08-14
Q1 2024 New 2,317,810 +2,317,810 (0.0%) 0.37% $114,083,000 2024-05-09
Q2 2022 Reduced 0 -206,054 (-100.0%) 0 $0 2022-08-12
Q1 2022 Reduced 206,054 -172,953 (-45.6%) 0.03% $11,629,000 2022-05-13
Q4 2021 Added 379,007 +25,091 (7.1%) 0.05% $23,490,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

248 managers reported SPRINGWORKS THERAPEUTICS IN for Q2 2024.

Managers reporting SPRINGWORKS THERAPEUTICS IN in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 11,112,391 +44,365 0.03% $418,603,769 20 qtrs
VANGUARD GROUP INC Added 6,544,413 +15,088 < 0.01% $246,528,038 20 qtrs
BlackRock Inc Added 5,619,260 +180,403 < 0.01% $211,677,525 20 qtrs
Deep Track Capital LP Added 3,700,000 +220,147 4.16% $139,379,000 8 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 3,602,234 -508,228 0.02% $135,697,000 15 qtrs
Boxer Capital LLC Unchanged 3,421,541 0 6.79% $128,889,449 20 qtrs
STATE STREET CORPORATION Added 3,086,845 +125,221 < 0.01% $116,281,451 19 qtrs
MAVERICK CAPITAL LTD Added 2,600,524 +691,894 1.86% $97,961,739 4 qtrs
MARSHALL WACE LLP Reduced 2,333,117 -633,505 0.12% $87,888,517 6 qtrs
LORD ABBETT & CO LLC This report Reduced 2,073,970 -243,840 0.26% $78,126,000 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 14, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
2,040,492
Shared
0
None
33,478

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.